草地贪夜蛾雄性成虫和5龄幼虫的转录组比较分析

【目的】草地贪夜蛾Spodoptera frugiperda是一种新近入侵我国的重要害虫。本研究旨在对草地贪夜蛾雄性成虫和5龄幼虫两个不同发育阶段的转录组进行比较分析。【方法】利用高通量测序技术对草地贪夜蛾雄性成虫和5龄幼虫进行转录组测序和数据组装,并对转录组数据进行功能注释和比较分析。【结果】经de novo组装共获得209 002条转录本,平均长度为687.55 bp,N50为982 bp。共有46 198条(57.43%) unigene在至少一个数据库中获得功能注释,其中1 713条(2.13%) unigene在所有数据库中均能获得注释。在GO数据库中获得205 269条unigene的注释,主要包括68个功能分类;在KEGG数据库中共有3 408条unigene得到注释,涉及277个代谢通路。共鉴定到424个嗅觉相关的基因,并且在雄性成虫和5龄幼虫之间的表达存在差异。通过比较转录组分析,在雄性成虫中鉴定到9 162个上调和6 399个下调差异表达基因(DEGs);功能富集分析发现在上调DEGs中涉及信息素以及信号转导的代谢通路显著富集,而下调DEGs中涉及解毒相关的通路显著富集。【结论】这些转录组数据为探究草地贪夜蛾的生长发育、嗅觉相关功能基因以及候选分子靶标提供资源信息。     

松墨天牛漆酶基因MaLac1的克隆、原核表达及表达谱分析

【目的】本研究旨在克隆并鉴定松墨天牛Monochamus alternatus内源漆酶基因MaLac1,分析其在松墨天牛不同发育阶段的表达水平,为进一步明确MaLac1功能提供依据。【方法】基于松墨天牛肠道转录组测序数据,通过RACE克隆松墨天牛MaLac1基因的全长cDNA序列,并对其进行生物信息学分析;将该基因与pET-32a载体链接构建表达载体pET-MaLac1,导入大肠杆菌Escherichia coli Rosetta (DE3)使其表达;使用qPCR检测MaLac1基因在松墨天牛不同发育阶段(低龄幼虫、老熟幼虫、蛹、雌成虫和雄成虫)肠道中的表达差异。【结果】克隆获得松墨天牛MaLac1的cDNA全长序列(GenBank登录号:KY073340)。MaLac1开放阅读框全长2 067 bp,编码一个含688个氨基酸的蛋白质,预测分子量为78.34 kD,等电点为5.30。SignalP 4.1 Server预测MaLac1在N端包含一个15个氨基酸的信号肽。序列比对分析表明,MaLac1具有典型的昆虫漆酶基因特征,与赤拟谷盗Tribolium castaneum漆酶基因的氨基酸序列一致性达93%。SDS-PAGE检测发现IPTG诱导表达了一条大约78 kD的特异蛋白条带,与推测大小一致。qPCR结果显示,MaLac1在不同发育阶段的松墨天牛肠道中均有表达,其中,在雌成虫肠道中表达量最高,在雄成虫肠道中的次之,在幼虫肠道中的最低。【结论】MaLac1在松墨天牛成虫中表达量显著高于其在幼虫中的,这一结果可能与幼虫和成虫的取食习性差异相关。MaLac1在松墨天牛体内的功能还有待进一步研究。     

草地贪夜蛾幼虫在玉米和小麦上的取食和生长发育特性比较

【目的】评估草地贪夜蛾Spodoptera frugiperda转移至小麦上为害和暴发的风险。【方法】采用室内饲养观察与调查统计的方法,测定和比较了23℃下草地贪夜蛾在玉米和小麦上的取食和生长发育特性及种群生命表参数。【结果】草地贪夜蛾在小麦上可以完成世代,其3龄后幼虫取食小麦的取食量及体重指标显著地高于同处理后时间在玉米上取食的;而食物利用效率、幼虫存活率、幼虫发育历期、卵孵化率均显著低于取食玉米的。取食玉米和取食小麦的草地贪夜蛾的平均蛹重、产卵前期、单雌产卵量等指标间无显著差异。另外,生命表参数比较结果表明,取食玉米和取食小麦的草地贪夜蛾的平均世代周期(T)、内禀增长率(r_m)和周限增长率(λ)间均无显著差异,取食玉米的草地贪夜蛾的净增殖率(R_0)为303.55±2.04,显著高于取食小麦的。【结论】草地贪夜蛾取食小麦时,生长发育速度快,能够完成世代生活史,但其食物利用效率、种群繁殖能力等却均低于取食玉米时,说明草地贪夜蛾更适宜在玉米上取食为害,存在转移至小麦为害的风险,但考虑到虫源、自然温度等条件,草地贪夜蛾在小麦上暴发的风险较小。本研究结果为明确草地贪夜蛾在小麦上为害和暴发的风险以及草地贪夜蛾的科学防控提供了理论依据。     

蚯蚓提取物对家蚕中肠氧化损伤、总抗氧化能力及抗氧化酶含量的影响

【目的】研究蚯蚓提取物对家蚕Bombyx mori中肠组织氧化应激及抗氧化酶含量的影响,探究蚯蚓提取物的抗氧化功能。【方法】分别给家蚕5龄幼虫饲喂蚯蚓(赤子爱胜蚓Eisenia foetida)提取液原液的50, 100和200倍稀释液处理后的桑叶,测定处理6 d后家蚕中肠组织中氧化损伤产物丙二醛(MDA)和乳酸脱氢酶(LDH)的含量;利用qRT-PCR检测家蚕中肠组织中抗氧化酶关键基因(Cat,Sod和GSH-Px)的mRNA表达水平;同时采用ELISA法检测中肠组织中抗氧化酶[过氧化氢酶(CAT)、超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GSH-Px)]含量及总抗氧化能力(T-AOC)。【结果】与对照组相比,50, 100和200倍稀释组家蚕中肠组织中MDA, CAT, SOD和GSH-Px含量及T-AOC均差异不显著,200倍稀释组LDH含量显著降低了9.85%,100倍稀释组中肠中Cat和GSH-Px的表达量均显著高于对照组,3个稀释组中Sod的表达量均显著高于对照组。【结论】添食蚯蚓提取物可通过降低家蚕中肠LDH含量、提高抗氧化酶基因的表达水平进而提高家蚕的抗氧化能力。     

Five genes as a novel signature for predicting the prognosis of patients with laryngeal cancer

In this study, we purpose to investigate a novel five-gene signature for predicting the prognosis of patients with laryngeal cancer. The laryngeal cancer datasets were obtained from The Cancer Genome Atlas (TCGA). Both univariate and multivariate Cox regression analysis was applied to screening for prognostic differential expressed genes (DEGs), and a novel gene signature was obtained. The performance of this Cox regression model was tested by receiver operating characteristic (ROC) curves and area under the curve (AUC). Further survival analysis for each of the five genes was carried out through the Kaplan-Meier curve and Log-rank test. Totally, 622 DEGs were screened from the TCGA datasets in this study. We construct a five-gene signature through Cox survival analysis. Patients were divided into low- and high-risk groups depending on the median risk score, and a significant difference of the 5-year overall survival was found between these two groups (P < .05). ROC curves verified that this five-gene signature had good performance to predict the prognosis of laryngeal cancer (AUC = 0.862, P < .05). In conclusion, the five-gene signature consist of EMP1, HOXB9, DPY19L2P1, MMP1, and KLHDC7B might be applied as an independent prognosis predictor of laryngeal cancer.     

Genome-Wide Analysis of NAC Transcription Factors and Characterization of the Cold Stress Response in Sweet Osmanthus

Plant Molecular Biology Reporter - Sweet osmanthus (Osmanthus fragrans) is an evergreen aromatic woody tree widely used in landscaping. However, O. fragrans is very sensitive to cold stress, which...     

Partial least squares for functional joint models with applications to the Alzheimer's disease neuroimaging initiative study

Many biomedical studies have identified important imaging biomarkers that are associated with both repeated clinical measures and a survival outcome. The functional joint model (FJM) framework, proposed by Li and Luo in 2017, investigates the association between repeated clinical measures and survival data, while adjusting for both high-dimensional images and low-dimensional covariates based on the functional principal component analysis (FPCA). In this paper, we propose a novel algorithm for the estimation of FJM based on the functional partial least squares (FPLS). Our numerical studies demonstrate that, compared to FPCA, the proposed FPLS algorithm can yield more accurate and robust estimation and prediction performance in many important scenarios. We apply the proposed FPLS algorithm to a neuroimaging study. Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database.     

Deregulation of UCA1 expression may be involved in the development of chemoresistance to cisplatin in the treatment of non-small-cell lung cancer via regulating the signaling pathway of microRNA-495/NRF2

Non-small-cell lung cancer (NSCLC) remains the leading cause of cancer death worldwide. As a platinum-based chemotherapeutic drug, cisplatin has been used for over 30 years in NSCLC treatment while its effects are diminished by drug resistance. Therefore, we aimed to study the potential role of UCA1 in the development of chemoresistance against cisplatin. Real-time polymerase chain reaction, western-blot analysis, and immunofluorescence were used to study the involvement of UCA1, miR-495, and NRF2 in chemoresistance against cisplatin. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was performed to determine the effect of cisplatin on cell proliferation. Computational analysis and luciferase assay were carried out to explore the interaction among UCA1, miR-495, and NRF2. The cisplatin-R group exhibited lower levels of UCA1 and NRF2 expression but a higher level of miR-495 expression than the cisplatin-S group. The growth rate and half-maximal inhibitory concentration of cellular dipeptidyl peptidase (cisplatinum) of the cisplatin-R group were much higher than those in the cisplatin-S group. MiR-495 contained a complementary binding site of UCA1, and the luciferase activity of wild-type UCA1 was significantly reduced after the transfection of miR-495 mimics. MiR-495 directly targeted the 3′-untranslated region (3′-UTR) of NRF2, and the luciferase activity of wild-type NRF2 3′-UTR was evidently inhibited by miR-495 mimics. Finally, UCA1 and NRF2 expressions in the effective group were much lower than that in the ineffective group, along with a much higher level of miR-495 expression. We suggested for the first time that high expression of UCA1 contributed to the development of chemoresistance to cisplatin through the UCA1/miR-495/NRF2 signaling pathway.     

Identification of novel LncRNA targeting Smad2/PKCα signal pathway to negatively regulate malignant progression of glioblastoma

Glioblastoma multiforme (GBM) is a highly proliferative cancer with generally poor prognosis and accumulating evidence has highlighted the potential of long noncoding RNAs (lncRNAs) in the biological behaviors of glioma cells. This study focused on the identification of lncRNAs to identify targets for possible GBM prognosis. Microarray expression profiling found that 1,759 lncRNAs and 3,026 messenger RNAs (mRNAs) were upregulated, and 1932s lncRNA and 2,979 mRNAs were downregulated in GBM. Bioinformatics analysis and experimental verification identified TCONS_00020456 (TCON) for further analysis. In situ hybridization, along with immunohistochemical and receiver operating characteristic analysis determined TCON (truncation value = 3.5) as highly sensitive and specific in GBM. Grade IV patients with glioma life span with different lncRNA staining scores were analyzed. TCON staining scores below 3.5 indicated poor prognosis (life span ranging from 0.25 to 7 months), even if the glioma was surgically removed. TCON decreased significantly in GBM, and showed a coexpressional relationship with Smad2 and protein kinase C α (PKCα). Overexpression of TCON reduced the proliferation on one hand and migration, invasion on the other. TCON also inhibited epithelial–mesenchymal transformation and glioma progression in vivo, based on a nude mouse tumorigenicity assay. In addition, we predicted a potential binding site and intersection that microRNAs targeting Smad2, PKCα, and TCON through RACE pretest and bioinformatics analysis. Taken together, TCON, regarded as oncosuppressor, targeting the Smad2/PKCα axis plays a novel role in inhibiting the malignant progression of glioma. Moreover, it also demonstrates that the level of TCON can be used as a prognostic and diagnostic biomarker for GBM.